Search Results

• • 7 

    Academic Journals

  • Sort by: sorttype.publication.date.desc Newest sorttype.publication.date.asc Oldest sorttype.relevance Relevance

• Select Oncological and urinary outcomes following low-dose-rate brachytherapy with a median follow-up of 11.8years.

  1

  Oncological and urinary outcomes following low-dose-rate brachytherapy with a median follow-up of 11.8years.

  Authors:William John Yaxley, James Mackean, Devang J. Desai, Gail Tsang, Judi Dixon, Hemamali Samaratunga, et al.From:BJU International (Vol. 130, Issue S3) Peer-Reviewed

  Nov. 2022292 words Report, Brief articl...

   Abstract Only
• Select Event-free survival after radical prostatectomy according to prostate-specific membrane antigen-positron emission tomography and European Association of Urology biochemical recurrence risk groups.

  2

  Event-free survival after radical prostatectomy according to prostate-specific membrane antigen-positron emission tomography and European Association of Urology biochemical recurrence risk groups.

  Authors:Matthew J. Roberts, Mark D. Chatfield, George Hruby, Rohan Nandurkar, Paul Roach, Jo Anne Watts, et al.From:BJU International (Vol. 130, Issue S3) Peer-Reviewed

  Nov. 2022442 words Report

   Abstract Only
• Select Guideline of guidelines: management of recurrent urinary tract infections in women.

  3

  Guideline of guidelines: management of recurrent urinary tract infections in women.

  Authors:Michael Kwok, Stephen McGeorge, Johanna Mayer-Coverdale, Bianca Graves, David L. Paterson, Patrick N.A. Harris, et al.From:BJU International (Vol. 130, Issue S3) Peer-Reviewed

  Nov. 2022331 words Report, Brief articl...

   Abstract Only
• Select Technetium-99m-sestamibi single-photon emission computerised tomography (CT)/CT in the prediction of malignant versus benign small renal masses.

  4

  Technetium-99m-sestamibi single-photon emission computerised tomography (CT)/CT in the prediction of malignant versus benign small renal masses.

  Authors:Pravin Viswambaram, Nicole Swarbrick, Alarick Picardo, Andrew Hohnen, Kevin Pham, William Macdonald, et al.From:BJU International (Vol. 130, Issue S3) Peer-Reviewed

  Nov. 2022256 words Report, Brief articl...

   Abstract Only
• Select Funding of all issues related to prostate cancer treatment should be a priority and have equal access - a key to survivorship.

  5

  Funding of all issues related to prostate cancer treatment should be a priority and have equal access - a key to survivorship.

  Author:Nathan LawrentschukFrom:BJU International (Vol. 130, Issue S3) Peer-Reviewed

  Nov. 202212 words Report, Brief articl...

   Abstract Only
• Select High prostate-specific membrane antigen (PSMA) positron emission tomography (PET) maximum standardized uptake value in men with PI-RADS score 4 or 5 confers a high probability of significant prostate cancer.

  6

  High prostate-specific membrane antigen (PSMA) positron emission tomography (PET) maximum standardized uptake value in men with PI-RADS score 4 or 5 confers a high probability of significant prostate cancer.

  Authors:Gideon Ptasznik, Nathan Papa, Brian D. Kelly, James Thompson, Phillip Stricker, Matthew J. Roberts, et al.From:BJU International (Vol. 130, Issue S3) Peer-Reviewed

  Nov. 202257 words Report, Brief articl...

   Abstract Only
• Select Prostate-specific membrane antigen positron emission tomography/computed tomography funding grants free access to superior staging for Australian men with prostate cancer.

  7

  Prostate-specific membrane antigen positron emission tomography/computed tomography funding grants free access to superior staging for Australian men with prostate cancer.

  Authors:Jonathan S. O'Brien, Aoife McVey, Brian D. Kelly, Pocharapong Jenjitranant, James Buteau, Michael S. Hofman, et al.From:BJU International (Vol. 130, Issue S3) Peer-Reviewed

  Nov. 202246 words Report, Brief articl...

   Abstract Only